Compare Davita Inc (DVA) vs iShares 10 20 Year Treasury Bond ETF (TLH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs iShares 10 20 Year Treasury Bond ETF — how do they compare? Davita Inc trades at $175.04 (market cap $11.28B), while iShares 10 20 Year Treasury Bond ETF trades at $92.19 (market cap $10.78B). The key difference: Davita Inc and iShares 10 20 Year Treasury Bond ETF are close in size by market cap, and Davita Inc is trading nearer its 52-week high, iShares 10 20 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Davita Inc for 113 Days and iShares 10 20 Year Treasury Bond ETF for 62 Days on average.
| DVA | TLH | |
|---|---|---|
Market Cap | $11.28B | $10.78B |
Volume | 650,294 | 4,408,295 |
Sector | Health | Fixed Income |
52-Week High | $240.96 | $105.36 |
52-Week Low | $103.87 | $91.34 |
Typical Hold Time | 113 Days | 62 Days |
Enterprise Value | $24.00B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $177.02, down 1.87% on the day, showing mixed technical signals with a bearish moving average trend but neutral oscillators. Fundamentally, the company demonstrates strong earnings beats with Q2 2026 EPS of $4.02 exceeding expectations of $3.88, while revenue growth continues from $13.64B in 2025 to projected $14.0B in 2026. Recent developments include expanding value-based care partnerships with Humana, potentially benefiting over 10,000 Medicare Advantage members.
The outlook remains cautiously optimistic with 43% analyst buy ratings and a $235.67 consensus price target suggesting 33% upside. However, rising debt-to-asset ratios (65.55% in 2025) and margin pressures from Q2 2026 create headwinds. Key risks include regulatory changes in healthcare reimbursement and competitive pressures in dialysis services.
TLH (iShares 10-20 Year Treasury Bond ETF) is trading at $91.45, down 0.12% with a bearish technical signal. The ETF shows unusually high trading volume and faces pressure from rising Treasury yields, which reached multi-decade highs recently. Dividend distributions continue with recent payments of $0.36-$0.38 per share, but key valuation ratios remain unavailable for analysis.
The outlook remains challenging as bond markets face persistent yield pressures from inflation concerns and Fed policy uncertainty. Investment opportunity exists for yield-seeking investors, but risks include continued bond market volatility and potential further yield increases that could pressure ETF prices lower.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About iShares 10 20 Year Treasury Bond ETF
TLH tracks the ICE U.S. Treasury 10-20 Year Bond Index, offering targeted exposure to intermediate-to-long term government debt. It serves as a middle ground between the 7-10 year (IEF) and 20+ year (TLT) ETFs, balancing yield and duration risk.
Read more on TLH →
